Abametapir

Class
Pediculicides
Subclass
Metalloproteinase inhibitors
Generic name
Abametapir
Brand names
Xeglyze®
Common formulations
Lotion
Dosage and administration
Adults patients
Treatment of head lice
0.74% TOP once
Indications for use
Labeled indications
Adults
Treatment of head lice
Children
Treatment of head lice
Specific populations
Renal impairment
eGFR 0-90 mL/min/1.73 m²
Use acceptable. No dose adjustment required.
Renal replacement therapy
Any modality
Use acceptable. No dose adjustment required.
Hepatic impairment
Any severity
No guidance available.
Pregnancy and breastfeeding
Pregnancy
All trimesters • Australia Category: C
Use only if benefits outweigh potential risks. Evidence of fetal harm in animals.
Adverse reactions
Common 1-10%
Contact dermatitis, burning sensation, eye irritation, hair discoloration, skin rash, vomiting, skin erythema
Unknown frequency
Drug hypersensitivity reaction, scalp erythema
Interactions
Drug(s)
Check Interactions
Reset

What did you think about this content?

Sign up for free to access the full drug resource